The Effects of Atorvastatin on Arterial Stiffness in Male Patients with Type 2 Diabetes
Table 1
Baseline characteristics of the study cohort, divided into 10 and 80 mg groups.
10 mg
80 mg
value
()
()
Age (years)
67 (46–84)
67 (43–85)
0.72
Total cholesterol (mmol/L)
5.5 ± 1
5.6 ± 1.2
0.75
Low-density lipoprotein (mmol/L)
3.6 ± 0.6
3.4 ± 0.8
0.41
HbA1c (mmol/mol)
52.5 ± 4.1
51.2 ± 4.5
0.39
HbA1c (%)
6.9 ± 0.8
6.8 ± 0.8
0.39
eGFR (mL/min/1.73 m2)
81.7 (61.7–141.4)
98.7 (60.5–145.5)
0.67
Smoking (%)
12 (3/25)
27 (7/26)
0.29
Duration of diabetes (years)
7 (1–22)
8 (2–19)
0.78
Body mass index (kg/m2)
31.2 ± 6.7
32.4 ± 4.7
0.85
Systolic BP (mmHg)
140 (120–157)
139 (130–150)
0.87
Diastolic BP (mmHg)
80 (72–90)
80 (59–90)
0.89
Data are presented as mean ± standard deviation (SD), median (25th–75th centile), or absolute numbers as appropriate. BP: blood pressure; eGFR: estimated glomerular filtration rate; HbA1c: glycated hemoglobin.
